MIS-C sequel to COVID-19 infection, diagnostic challenge and management - a case report

Keywords: COVID-19, Diagnosis, MISC-C

Abstract

Multisystem inflammatory syndrome in children (MIS-C) is a rare sequel to severe acute respiratory syndrome coronavirus (SARS-CoV-2). Clinical picture of MIS-C includes multi system inflammation alongside fever and severe illness with laboratory evidence of raised inflammatory markers. MIS-C may resemble toxic shock syndrome, complete or incomplete Kawasaki disease and macrophage activation syndrome. Actual management of MIS-C is yet to be formulated, currently treatment is supportive only. In addition, as MIS-C is a new clinical entity we do not know about its long-term prognosis.

Author Biographies

Subash Paudeal, Patan Academy of Health Sciences, Lalitpur, Kathmandu, Nepal

Resident, Department of Paediatrics, Patan Hospital

Sunl Kumar Das, Patan Academy of Health Sciences, Lalitpur, Kathmandu, Nepal

Resident, Department of General Practice and Emergency Medicine, Patan Hospital

Published
2021-07-14
Section
Case Report